Market Tracker

03/30 6:26am ET

Merck & Co Inc (NYSE:MRK)

63.64
Delayed Data
As of Mar 29
 +0.30 / +0.47%
Today’s Change
52.44
Today|||52-Week Range
66.80
+8.10%
Year-to-Date
VBI Vaccines Emerges as Strong Biotech Stock
Mar 29 / TheStreet.com - Paid Partner Content
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Mar 24 / Zacks.com - Paid Partner Content
Orbimed Advisors Llc Buys Anthem, Alexion Pharmaceuticals, Aetna, Sells WellCare Heal...
Mar 28 / GuruFocus News - Paid Partner Content
Merck Is Dangerously Close to a Breakdown
Mar 24 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY) Opdivo Gets Positive CHMP Opinion
Mar 28 / Zacks.com - Paid Partner Content
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
Mar 24 / TheStreet.com - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
Merck Closes Acquisition of Controlling Stake in Vallee S.A
Mar 23 / Zacks.com - Paid Partner Content
Merck wins approval for skin cancer treatment
Mar 24 / FT.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, General Electric, MasterCard and NVIDIA
Mar 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.34
Today’s open63.67
Day’s range63.46 - 64.11
Volume8,135,333
Average volume (3 months)10,363,669
Market cap$173.9B
Dividend yield2.95%
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+0.80%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+1.86%
P/E ratio45.1
Price/Sales4.15
Price/Book4.34

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.02+0.03%
PFEPfizer+0.17+0.50%
SNYSanofi-0.08-0.18%
ABBVAbbVie-0.21-0.32%
Data as of 03/29/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts